Sector: Health Care
Director information for CARDINAL HEALTH INC (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Akhil Johri | Operating Advisor to CD&R; Former EVP and CFO, United Technologies Corporation | 64 | ["Operating Advisor to CD&R", "Former EVP and CFO, United Technologies Corporation", "Over 25 years of financial leadership experience", "Deep expertise in global finance and accounting", "Investor relations", "Capital markets", "Mergers and acquisitions", "Tax", "Information technology", "International operations", "Extensive experience in financial reporting and internal controls", "Strong understanding of financial management and capital deployment strategies", "Governance experience from service on the board of directors of Boeing"] | ["Finance Committee", "Audit Committee"] | 2025 |
| Christine A. Mundkur | Former CEO, Impopharma Inc.; Director | 56 | ["Former CEO, Impopharma Inc.", "Over 20 years of leadership experience in the pharmaceutical industry", "Executive roles in legal, quality and regulatory compliance, manufacturing operations, and strategic consulting", "Expertise in healthcare, corporate governance, international markets, and finance", "Former CEO and non-voting Chair of Impopharma Inc.", "Former President of CM Strategic Advisors", "Former President and CEO of Sandoz, Inc.", "Former CEO of Barr Laboratories, Inc.", "Extensive experience in quality and regulatory departments at Barr Pharmaceuticals"] | ["Audit Committee", "Nominating and Corporate Governance Committee"] | 2025 |
| David C. Evans | Former EVP and CFO, The Scotts Miracle-Gro Company; Director | 62 | ["Former EVP and CFO, The Scotts Miracle-Gro Company", "Over 25 years of financial leadership experience", "CFO at Scotts Miracle-Gro and Battelle", "Expertise in financial reporting and internal controls", "Strong understanding of capital deployment and financial operations", "Interim CFO at Cardinal Health", "Interim CFO of The Scotts Miracle-Gro Company", "Executive Vice President and CFO of Battelle Memorial Institute", "Executive Vice President, Strategy and Business Development of Scotts Miracle-Gro"] | ["Audit Committee", "Finance Committee"] | 2025 |
| Gregory B. Kenny | Former President and CEO, General Cable Corporation; Chairman of the Board | 72 | ["Former President and CEO, General Cable Corporation", "Chairman of the Board since November 2018", "President and Chief Executive Officer of General Cable for 14 years", "Deep expertise in corporate governance, global manufacturing operations, international markets, finance, and human capital management", "Chair of the Governance and Sustainability and Compensation Committees", "Valuable governance insight from chairing the board of Ingredion and its Corporate Governance and Nominating Committee", "Executive positions at General Cable and Penn Central Corporation", "Foreign Service Officer at the U.S. Department of State"] | ["Governance and Sustainability Committee", "Compensation Committee"] | 2025 |
| Jason M. Hollar | CEO, Cardinal Health, Inc.; Chief Executive Officer | 52 | ["CEO, Cardinal Health, Inc.", "Extensive leadership experience in executive, financial, and operational management", "Expertise in financial strategy, capital deployment, tax, investor relations, accounting, and financial reporting", "Significant experience in capital markets, mergers and acquisitions, and international operations", "Experience in information technology, corporate governance, human capital management, and regulatory compliance"] | ["Audit Committee"] | 2025 |
| Michelle M. Brennan | Former Value Creation Leader, Johnson & Johnson; Interim CEO | 60 | ["Former Value Creation Leader, Johnson & Johnson", "Wealth of experience in senior management roles at Johnson & Johnson", "Expertise in healthcare, regulatory compliance, manufacturing operations, product quality, strategic planning, finance, and global markets", "Chairman of the Board at Masimo", "Chair of the Nominating and Corporate Governance Committee at Coupa Software"] | ["Nominating, Compliance and Corporate Governance Committee", "Audit Committee"] | 2025 |
| Nancy Killefer | Former Senior Partner, Public Sector Practice, McKinsey & Company, Inc. | 71 | ["Former Senior Partner, Public Sector Practice, McKinsey & Company, Inc.", "Over 30 years of strategic leadership experience", "Advised healthcare and consumer-focused organizations on strategic planning", "Former Managing Partner of McKinsey\u2019s Public Sector Practice", "Former Chief Financial Officer of a U.S. government agency", "Expertise in government relations, public policy, and financial oversight", "Senior Partner of McKinsey & Company, Inc.", "Founder and Managing Partner of McKinsey\u2019s Public Sector Practice", "Assistant Secretary for Management, CFO, and Chief Operating Officer for the U.S. Department of Treasury"] | ["Compensation Committee", "Nominating and Corporate Governance Committee", "Audit and Privacy Committee"] | 2025 |
| Patricia A. Hemingway Hall | Former President and CEO, Health Care Service Corporation; President and Chief Executive Officer | 72 | ["Former President and CEO, Health Care Service Corporation", "retired President and Chief Executive Officer of Health Care Service Corporation", "expertise in healthcare delivery, insurance, and policy", "led HCSC from 2008 to 2016", "experience in healthcare reform, regulatory compliance, government relations, finance, information technology, human capital management"] | ["Governance and Sustainability", "Audit"] | 2025 |
| Robert W. Azelby | Former President and CEO, Eliem Therapeutics, Inc. | 57 | ["Former President and CEO, Eliem Therapeutics, Inc.", "extensive executive leadership experience across the biopharmaceutical, oncology, and specialty pharmaceutical sectors", "strategic oversight and operational leadership", "corporate governance", "commercial and manufacturing operations", "international markets", "finance", "human resources", "regulatory compliance"] | ["Audit Committee", "Compensation Committee"] | 2025 |
| Robert W. Musslewhite | Former CEO, Definitive Healthcare Corp.; Director | 55 | ["Former CEO, Definitive Healthcare Corp.", "over two decades of executive leadership experience across healthcare technology, data analytics, and strategic consulting", "senior roles in corporate strategy, product scaling, and operational leadership", "CEO of Definitive Healthcare", "held multiple CEO roles within UnitedHealth Group\u2019s Optum division", "Chairman and CEO of The Advisory Board Company", "extensive leadership and board experience in healthcare innovation, data-driven strategy, public company governance, finance, human capital management, and regulatory compliance"] | ["Compensation Committee", "Capital Allocation Committee"] | 2025 |
| Sheri H. Edison | Former EVP and General Counsel, Amcor plc; Executive Vice President and General Counsel | 68 | ["Former EVP and General Counsel, Amcor plc", "extensive executive leadership experience", "served as General Counsel", "senior functional roles at publicly traded manufacturing companies", "experience in private legal practice", "broad-based business acumen", "navigating complex commercial, legal, and regulatory environments"] | ["Corporate Governance, Nominating, and Sustainability Committee", "Compensation and Talent Committee"] | 2025 |
| Sudhakar Ramakrishna | President and CEO, SolarWinds Corporation | 57 | ["President and CEO, SolarWinds Corporation", "Over 25 years of leadership experience in the technology sector", "Expertise in cybersecurity, enterprise software, and IT infrastructure", "Led significant technology and business model transformations at SolarWinds", "Previous CEO of Pulse Secure", "Held senior leadership roles at Citrix Systems, Polycom, Motorola, and 3COM", "Experience in global IT operations, infrastructure modernization, and operational resilience", "Served on public company boards of Enterprise 4.0 Technology Acquisition Corp. and SailPoint Technologies", "Advisory partner at Benhamou Global Ventures"] | [] | 2025 |
